Company Filing History:
Years Active: 2020-2025
Title: Innovations in Cancer Treatment by KiBem Kim
Introduction
KiBem Kim is an accomplished inventor based in Lutherville, MD (US). He has made significant contributions to the field of cancer treatment, particularly through his innovative approaches involving immunotherapy. With a total of 2 patents, his work focuses on enhancing the efficacy of cancer therapies.
Latest Patents
One of KiBem Kim's latest patents is titled "Use of bacteria, bacterial products, and other immunoregulatory entities in combination with anti-CTLA-4 and/or anti-PD-1 antibodies to treat solid tumor malignancies." This patent outlines methods and kits for treating solid tumors by utilizing a combination of anti-CTLA-4 and/or anti-PD-1 antibodies along with specific bacteria or immunoregulatory entities. Notably, the bacteria used in this method are toxin-depleted, anaerobic bacteria, which have shown promise in enhancing treatment outcomes.
Another significant patent is "Suppression of myeloid derived suppressor cells and immune checkpoint blockade." This invention addresses the challenges faced in immunotherapy against poorly immunogenic cancers. The research indicates that co-treatment with epigenetic modulating drugs and checkpoint inhibitors can markedly improve treatment outcomes, curing over 80% of treated subjects. The findings suggest that targeting myeloid-derived suppressor cells (MDSCs) can lead to successful treatment of cancers resistant to immune checkpoint blockade.
Career Highlights
KiBem Kim has worked with prestigious institutions, including The Johns Hopkins University and Biomed Valley Discoveries, Inc. His research has contributed to the understanding and development of innovative cancer therapies that leverage the immune system's capabilities.
Collaborations
Throughout his career, KiBem Kim has collaborated with notable figures in the field, including Shibin Zhou and Bert Vogelstein. These collaborations have furthered the research and development of effective cancer treatments.
Conclusion
KiBem Kim's innovative work in cancer treatment exemplifies the potential of combining immunotherapy with novel biological entities. His patents reflect a commitment to advancing medical science and improving patient outcomes in the fight against cancer.